Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab

The recent introduction of direct oral anticoagulants, including rivaroxaban, dabigatran, apixaban, and edoxaban, for the acute treatment and secondary prevention of venous thromboembolism and in atrial fibrillation has been shown to provide greater clinical benefit than oral vitamin K antagonists....

Descripción completa

Detalles Bibliográficos
Autores principales: Riario Sforza, Gian Galeazzo, Gentile, Francesco, Stock, Fabio, Caggiano, Francesco, Chiocca, Enrica, Incorvaia, Cristoforo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768245/
https://www.ncbi.nlm.nih.gov/pubmed/29348918
http://dx.doi.org/10.1177/2050313X17753336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768245/
https://www.ncbi.nlm.nih.gov/pubmed/29348918
http://dx.doi.org/10.1177/2050313X17753336

Ejemplares similares